Tianjin Jiuri New Materials Co Ltd

Jiuri New Materials disclosed its 2026 half-year report. First-half operating revenue reached 867 million yuan, up 21.58 percent year on year. Net profit attributable to shareholders of the listed company was 43.41 million yuan, compared with a loss of 9.06 million yuan in the same period last year, swinging to a profit. Basic earnings per share were 0.27 yuan. The company said prices of some major photoinitiator products rebounded, and combined with continued cost reduction and efficiency improvement, overall gross profit increased from a year earlier. In addition, the share price of Xiamen Hengkung New Material Technology, in which the Tianjin Ruiwu Equity Investment Fund Partnership that the company co-established has invested, continued to climb. Ruiwu Fund's net profit continued to rise sharply, and the company's corresponding investment income increased.

Jiuri New Materials announced that its wholly-owned subsidiary Shandong Jiuri Chemical Technology has passed the review for the trial production plan of ACMO Phase One, part of the "18,340 tonnes per year photocuring materials and photoresist intermediates construction project," and has entered the trial production stage. The total designed capacity for ACMO is 1,500 tonnes per year, with the Phase One capacity brought into production this time at 500 tonnes per year.